Sickle cell disease and perioperative considerations: Review and retrospective report

Journal of Oral and Maxillofacial Surgery

Volumn 71, Issue 6, 2013, Pages 1027-1033

  Stanley, Adam C ^a   Christian, James M ^a  

^a UNIVERSITY OF TENNESSEE HEALTH SCIENCE CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMOXICILLIN; AMPICILLIN; ANTIBIOTIC AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; CLINDAMYCIN; FENTANYL; HYDROXYUREA; INFUSION FLUID; LORAZEPAM; NARCOTIC AGENT; OXYGEN; PENICILLIN V; SEDATIVE AGENT;

ANESTHESIA INDUCTION; ANTIBIOTIC PROPHYLAXIS; ANTIBIOTIC THERAPY; ARTICLE; CLINICAL PROTOCOL; DEHYDRATION; ERYTHROCYTE TRANSFUSION; FLUID THERAPY; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; LOCAL ANESTHESIA; MAXILLOFACIAL SURGERY; MEDICAL RECORD REVIEW; ORAL SURGERY; OXYGEN THERAPY; PERIOPERATIVE PERIOD; POSTOPERATIVE COMPLICATION; POSTOPERATIVE INFECTION; RETROSPECTIVE STUDY; RISK FACTOR; SEDATION; SICKLE CELL ANEMIA; SURGICAL PATIENT; THERMOREGULATION;

AMBULATORY SURGICAL PROCEDURES; ANEMIA, SICKLE CELL; ANTIBIOTIC PROPHYLAXIS; DENTAL CARE FOR CHRONICALLY ILL; HEMOGLOBIN, SICKLE; HUMANS; INTRAOPERATIVE COMPLICATIONS; ORAL SURGICAL PROCEDURES; OXYGEN; PERIOPERATIVE PERIOD; RETROSPECTIVE STUDIES;

EID: 84878114625     PISSN: 02782391     EISSN: 15315053     Source Type: Journal    
DOI: 10.1016/j.joms.2012.12.004     Document Type: Article

References (13)

1. National Heart, Lung, and Blood Institute Disease and Conditions Index. Sickle Cell Anemia: Who Is at Risk? 2009 US Department of Health and Human Services, National Institutes of Health, National Heart, Lung, and Blood Institute Bethesda, MD Available at: http://www.nhlbi.nih.gov/health/dci/ Diseases/Sca/SCA-WhoIsAtRisk.html Accessed March 29, 2012
2. C.T. Quinn, Z.R. Rogers, and T.L. McCavit Improved survival of children and adolescents with sickle cell disease Blood 115 2010 17
3. P. Firth Anesthesia and hemoglobinopathies Anesthesiol Clin 27 2009 321
4. P. Firth, and C. Head Sickle cell disease and anesthesia Anesthesiology 101 2004 766
5. G.R. Serjeant Sickle-cell disease Lancet 350 1997 725
6. K.G. Harmon, J.A. Drezner, and D. Klossner Sickle cell trait associated with a RR of death of 37 times in national collegiate athletic association football athletes: A database with 2 million athlete-years as the denominator Br J Sports Med 46 2012 325
7. J.B. Herrick Peculiar elongated and sickle-shaped red blood corpuscles in a case of severe anemia Arch Intern Med 6 1910 517 521
8. D. Lawrenz Sickle cell disease: A review and update of current therapy J Oral Maxillofac Surg 57 1999 171
9. K. Kaushansky, M.A. Lichtman, and E. Beutler Williams Hematology (ed 8) 2010 McGraw-Hill New York pp 715-724
10. J.P. Greer, J. Foerster, and G.M. Rodgers Wintrobe's Clinical Hematology (ed 12) 2009 Lippincott Williams & Wilkins Philadelphia, PA pp 1052-1059
11. R.M. Borle, M.C. Prasant, and S.J. Badjate Sickle cell osteomyelitis of the maxilla: A case report J Oral Maxillofac Surg 59 2001 1371
12. J.L. Dos Santos, and C. Lanaro Design, synthesis and pharmacological evaluation of novel hybrid compounds to treat sickle cell disease symptoms J Med Chem 54 2012 5811
13. S. Shenoy Hematopoietic stem cell transplantation for sickle cell disease: Current practice and emerging trends Hematology 1 2011 273